Pharmaceutical Market Europe • November 2025 • 3
COMMENT
The importance of accurate scientific testing
Our cover story this month features Martin Danielson, VP Global Marketing, ImmunoDiagnostics at Thermo Fisher Scientific. I spoke to Martin about allergy and autoimmune diseases, and the importance of accurate scientific testing. I asked Martin about what’s driving the growing demand for advanced immunoassays in allergy and autoimmune diseases, and how the company’s product portfolios are addressing this need. Turn to page 14 to find out more.
The ABC Global Alliance has launched the Advanced Breast Cancer (ABC) Global Decade Report 2015-2025. This landmark global assessment reveals a decade of remarkable scientific progress that has transformed ABC care for some patients in some countries, while many others around the world have yet to benefit. Find out more on page 18.
Prostate cancer remains one of the most prevalent malignancies affecting men worldwide. As Sarah Reynolds writes: ‘In the UK, prostate cancer is the most common cancer among men, with more than 63,000 men diagnosed every year and around 510,000 living with or after the disease. On average, one in eight men in the UK will be diagnosed with prostate cancer in their lifetime.’ Turn to page 22 to find out more.
We’re very excited that, this year, PMGroup celebrates the 25th year of the PMEAs, with the black tie event being held at the Sheraton Grand hotel in London. The PMEA programme rewards work that delivers clearly identifiable benefits and improved outcomes for patients, as well as societal value, in global, regional and local markets.
This year’s Awards included 20 categories, with the three new categories recognising: the Care Pathway Transformation; Excellence in Global/Local Connectivity and Value, and Contribution to the Future of Healthcare at Ecosystem Level. Turn to page 26 to see full coverage of the event, including photos of all the excitement from the night!
Our next issue, in January 2026, will look at building representation and authenticity into healthcare, from trials to campaigns. If you would like to make your voice heard on this topic, please get in touch at sales@pmlive.com
I hope you enjoy this issue!
Iona Everson
Group Managing Editor
Keep up to date with the latest developments in the UK and global healthcare marketplace – sign up to daily or weekly news alerts and fortnightly or monthly bulletins on specific topics at www.pmlive.com/register
THE TEAM
Editorial:
Group Managing Editor
Iona Everson
Journalist/Editorial Assistant
Esme Needham
Studio:
Executive Director
Karl Equi
Sales:
Business Director
Tara Lovegrove
EDITORIAL ADVISORY BOARD
Philip Atkinson
Founder of Hive-Logic, Lifescience Transformation
Uday Bose
Corporate vice president, head of global marketing oncology, Boehringer Ingelheim
Dr Luc Hermans
VP commercial planning and operations Europe, Asia, Middle East, Gilead Sciences
Stefan Janssens
President EMEA, Cegedim Dendrite
John Morris
Partner, KPMG
Paul Pay
Chief business development officer, Norgine
Mark Rothera
Chief executive officer, Orchard Therapeutics
Ian Talmage
Senior vice president, global marketing, general medicine, Bayer Pharmaceuticals
PUBLISHED BY
PMGroup Worldwide Ltd
44 Maiden Lane
Covent Garden
London
WC2E 7LN
CONTACT US
General enquiries: info@pmlive.com
Editorial: editor@pmlive.com
Advertising: sales@pmlive.com
Subscriptions: subscriptions@pmlive.com
Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.
© 2025 PMGroup
All rights reserved. No part of this publication may be copied, reproduced, transmitted, photocopied, recorded or stored on any retrieval system without the prior written consent of the publishers.
The magazine is also available at the following subscription rates: £120 UK, £180 Europe, £210 RoW
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services